Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases
GJM Herder,1 H Codrington,2 CD Colder,3 JG Aerts4,51St Antonius Hospital, Nieuwegein, The Netherlands; 2Haga Hospital, The Hague, The Netherlands; 3St Jansdal Hospital, Harderwijk, The Netherlands; 4Amphia Hospital, Breda; 5Erasmus MC Rotterdam, The NetherlandsIntroduction: Previous research showed...
Guardado en:
Autores principales: | Herder GJM, Codrington H, Colder CD, Aerts JG |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5b5fdb05a88e4542a6ff4adb45ba0468 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bevacizumab in the treatment of NSCLC: patient selection and perspectives
por: Russo AE, et al.
Publicado: (2017) -
A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survival
por: Sipeng Shen, et al.
Publicado: (2021) -
Surgical Insights Are Essential to Integration of Immune Therapy in Resectable NSCLC
por: Jessica S. Donington, MD
Publicado: (2021) -
AXL receptor tyrosine kinase as a therapeutic target in NSCLC
por: Okimoto RA, et al.
Publicado: (2015) -
MET overexpression and gene amplification in NSCLC: a clinical perspective
por: Landi L, et al.
Publicado: (2013)